In particular, CD8 T cells are central to tumor immunity, and tumor-infiltrating CD8 T cells are associated with increased patient survival (Martínez-Lostao et al., 2015; Liu et al., 2012; Mahmoud et al., 2012). Here, CD8A is linked to neoplasm.